Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Capivasertib plus abiraterone/prednisone with continued ADT is now indicated for PTEN-deficient mAPMN/S disease, supported by concurrent clearance of the VENTANA PTEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results